ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
321
Screening encounters
321
Diagnostic referrals
51
Outstanding pathways
47

Screening pathway

  1. Screening321Encounters
  2. Positive finding97Documented findings
  3. Referral51Diagnostic referrals
  4. Follow-up20Diagnostic visits
  5. Outcome4Resolved pathways

Stage totals use different units. Pending pathways: 47. Insufficient observation: 0.

Participant insight

Select a participant to review their screening history and referral-time risk.

Browse participants

Screened participants

321 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0776 · Expanded synthetic participant 0776Site B — Peri-Urban Access Programme
EXP-0802 · Expanded synthetic participant 0802Site C — Rural Outreach Programme
EXP-0837 · Expanded synthetic participant 0837Site D — Community Engagement Programme
EXP-0847 · Expanded synthetic participant 0847Site C — Rural Outreach Programme
EXP-0855 · Expanded synthetic participant 0855Site D — Community Engagement Programme
EXP-0867 · Expanded synthetic participant 0867Site B — Peri-Urban Access Programme
EXP-0872 · Expanded synthetic participant 0872Site E — Resource-Constrained Navigation Programme
EXP-0883 · Expanded synthetic participant 0883Site C — Rural Outreach Programme
EXP-0893 · Expanded synthetic participant 0893Site A — Urban Referral Hub
EXP-0894 · Expanded synthetic participant 0894Site A — Urban Referral Hub
EXP-0904 · Expanded synthetic participant 0904Site B — Peri-Urban Access Programme
EXP-0937 · Expanded synthetic participant 0937Site E — Resource-Constrained Navigation Programme
EXP-0942 · Expanded synthetic participant 0942Site C — Rural Outreach Programme
EXP-0952 · Expanded synthetic participant 0952Site C — Rural Outreach Programme
EXP-0956 · Expanded synthetic participant 0956Site A — Urban Referral Hub
EXP-0976 · Expanded synthetic participant 0976Site D — Community Engagement Programme
EXP-0978 · Expanded synthetic participant 0978Site C — Rural Outreach Programme
EXP-0988 · Expanded synthetic participant 0988Site D — Community Engagement Programme
EXP-0992 · Expanded synthetic participant 0992Site B — Peri-Urban Access Programme
EXP-0998 · Expanded synthetic participant 0998Site C — Rural Outreach Programme
EXP-1017 · Expanded synthetic participant 1017Site D — Community Engagement Programme
EXP-1029 · Expanded synthetic participant 1029Site A — Urban Referral Hub
EXP-1033 · Expanded synthetic participant 1033Site D — Community Engagement Programme
EXP-1039 · Expanded synthetic participant 1039Site B — Peri-Urban Access Programme
EXP-1072 · Expanded synthetic participant 1072Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
148
HPV DNA
121
Cytology
52

Navigation activity

Barrier documented
28
Contact attempt
69
Navigation intervention
11
Diagnostic booking
50
Diagnostic visit
20

Documented barriers

Contact difficulty
6
Transport difficulty
9
Appointment coordination
13

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.